Stock Details
BHC is Bausch Health Companies Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 18.86$. Average daily volumn in 3 months 6.24M. Market cap 3.46B



Stock symbol : BHC. Exchange : NYSE. Currency : USD
Lastest price : 9.58$. Total volume : 5.07M. Market state PREPRE
Click reload if you want to check the lastest price on market!!!

Bausch Health Companies Inc. (BHC)
Last Price
9.58$
Change
0.30
Volume
5.07M

Previous Close9.28
Open9.19
Day Range9.19-9.67
Bid0.00 x 1.8k
Ask0.00 x 1k
Volume5.07M
Average Volume6.24M
Market Cap3.46B
Beta1.62
52 Week Range7.80-32.54
Trailing P/EN/A
Foward P/E1.63
Dividend (Yield %)N/A
Ex-Dividend Date2010-11-10



Financial Details


According to Bausch Health Companies Inc.'s financial reports the company's revenue in 2021 were 8.43B an increase(0%) over the years 2020 revenue that were of 8.03B. In 2021 the company's total earnings were -948M while total earnings in 2020 were -560M( +69.29%).


Loading ...



Organization

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical... , and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Market Cap:
3.46B
Revenue:
8.43B
Total Assets:
29.2B
Total Cash:
582M


News about "Bausch Health Companies Inc."

bausch-health-companies-inc-nysebhc-expected-to-post-quarterly-sales-of-209-billion-image

Bausch Health Companies Inc. (NYSE:BHC) Expected to Post Quarterly Sales of $2.09 Billion

Source from : Defense World - 3 days ago

Analysts forecast that Bausch Health Companies Inc. (NYSE:BHC โ€“ Get Rating) will report sales of $2.09 billion for the current quarter, according to Zacks. Four analysts have provided estimates for ...See details»


Bausch Health Companies Inc. (BHC) Management on Barclays High Yield Bond & Syndicated Loan Conference (Transcript)

Source from : Seeking Alpha - 1 days ago

Barclays High Yield Bond & Syndicated Loan Conference May 24, 2022 12:00 PM ET Company Participants Tom Vadaketh - Chief Financial ...See details»


bausch-health-companies-inc-bhc-moved-down-065-why-its-important-image

Bausch Health Companies Inc. [BHC] moved down -0.65: Why Itโ€™s Important

Source from : dbtnews - 9 days ago

Bausch Health Companies Inc. (NYSE/TSX: BHC) (โ€œBausch Healthโ€ or the โ€œCompanyโ€) today announced that the Company will participate in several upcoming investor conferen ...See details»


BofA Securities lifts Bausch Health Companies Inc. [BHC] price estimate. Who else is bullish?

Source from : dbtnews - 2 days ago

Skillz Inc. stock went on a downward path... Bausch Health Companies Inc. [NYSE: BHC] slipped around -0.22 points on Friday, while shares priced at $9.93 at the close of the session, down -2.17%. The ...See details»


Bausch Health Companies Inc. (BHC) Is A Good Investment At Current Valuations

Source from : stocksregister - 6 days ago

Bausch Health Companies Inc. (NYSE:BHC) concluded the trading at $10.15 on Thursday, May 19 with a rise of 2.01% from its closing price on previous day. Taking a look at stock we notice that its last ...See details»


Bausch Health Companies Inc. Announces First-Quarter 2022 Results

Source from : Yahoo Finance - 15 days ago

2022 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company" or "we") today announced its first-quarter 2022 financial results. "Our organic 3 growth in the first ...See details»


Bausch Health Companies Inc. (BHC) CEO Joe Papa on Q1 2022 Results - Earnings Call Transcript

Source from : Seeking Alpha - 15 days ago

Unidentified Company Representative Good morning. Welcome everyone to our first quarter 2022 earnings conference call. Participating in todayโ€™s call are the Chairman of Bausch Health and Bausch ...See details»


bausch-health-receives-untitled-letter-from-opdp-over-statements-made-on-morning-show-image

Bausch Health Receives Untitled Letter from OPDP Over Statements Made on Morning Show

Source from : policymed.com - 6 days ago

On March 31, 2022, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent an untitled letter to Bausch Health over misleading statements the company ...See details»


july-1st-options-now-available-for-bausch-health-companies-bhc-image

July 1st Options Now Available For Bausch Health Companies (BHC)

Source from : Nasdaq - 13 days ago

I nvestors in Bausch Health Companies Inc (Symbol: BHC) saw new options become available today, for the July 1st expiration. At Stock Options Channel, our YieldBoost formula has l ...See details»


You Need to See this stock? Bausch Health Companies (BHC)

Source from : The Armenian Reporter - 10 days ago

Bausch Health Companies (BHC) disclosed a change of 3.73% and its listed share value at $10.84 in the recent trade transaction. This company belong to Canada ...See details»


bausch-health-and-bausch-lomb-corporation-announce-closing-of-initial-public-offering-of-bausch-lomb-and-related-debt-transactions-image

Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions

Source from : Stockhouse - 15 days ago

TSX:BHC) Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions ...See details»


bausch-lomb-receives-health-canada-approval-of-lumify-redness-reliever-eye-drops-image

Bausch + Lomb Receives Health Canada Approval of LUMIFYยฎ Redness Reliever Eye Drops

Source from : YAHOO!Finance - 2 days ago

Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today announced that Health Canada has approved ...See details»


Bausch Health Companies Inc. Will Release First-Quarter 2022 Financial Results On May 10'

Source from : Middle East North Africa Financial Network - 26 days ago

LAVAL, QC, April 29, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ('Bausch Health') will release its first-quarter financial results on Tuesday, May 10, 2022. Bausch Health ...See details»


Bausch Health Companies Inc.: Bausch + Lomb Corporation Announces Launch of IPO and Roadshow

Source from : Finanznachrichten - 27 days ago

About Bausch + Lomb Bausch + Lomb, a leading global eye health business of Bausch Health Companies, Inc., is dedicated to protecting and enhancing the gift of sight for millions of people around ...See details»